These outcomes were consistent with the literature review, which suggested that up-regulated PLCXD3 might contribute to the progression of NAFLD and AS due to its involvement in hyperinsulinemia and dyslipidemia. The gene discussed is PLCXD3; the disease is Hyperinsulinemia.